Michael Zilly
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 12
- Tuberculosis Research and Epidemiology 2
- Epidemiology 10
- Pneumocystis jirovecii pneumonia detection and treatment 8
- Co-authors
- Peter Langmann (17 shared papers)Hartwig Klinker (16 shared papers)Benedikt Weißbrich (5 shared papers)Ralf Winzer (5 shared papers)Steffen Desch (4 shared papers)Franz Tollmann (2 shared papers)Jörg Schubert (2 shared papers)Ernst Richter (2 shared papers)
In The Last Decade
Michael Zilly
17 papers receiving 365 citations
Peers
Comparison fields: 5 of 53
- Virology 169
- Infectious Diseases 281
- Emergency Medicine 73
- Pediatrics, Perinatology and Child Health 61
- Hepatology 24
Countries citing papers authored by Michael Zilly
This map shows the geographic impact of Michael Zilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Zilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Zilly more than expected).
Fields of papers citing papers by Michael Zilly
This network shows the impact of papers produced by Michael Zilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Zilly. The network helps show where Michael Zilly may publish in the future.
Co-authors
The 17 scholars most cited alongside Michael Zilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatment. | 2003 | 55 |
| 2 | 2004 | 53 | |
| 3 | 2001 | 38 | |
| 4 | 1999 | 36 | |
| 5 | Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patients. | 2002 | 33 |
| 6 | 2005 | 25 | |
| 7 | 2002 | 21 | |
| 8 | 2004 | 19 | |
| 9 | 1998 | 19 | |
| 10 | Therapeutic drug monitoring of saquinavir in patients during protease inhibitor therapy with saquinavir alone or in combination with ritonavir or nelfinavir. | 2000 | 19 |
| 11 | Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin. | 2002 | 17 |
| 12 | Influence of smoking on cotinine and caffeine plasma levels in patients with alcoholic liver cirrhosis. | 2000 | 13 |
| 13 | 2003 | 11 | |
| 14 | 2002 | 11 | |
| 15 | 2004 | 3 | |
| 16 | Drug monitoring of pyrimethamine during maintenance therapy of toxoplasmic encephalitis in patients with advanced HIV infection during HAART. | 2004 | 2 |
| 17 | 2006 | 1 |
About Michael Zilly
Michael Zilly is a scholar working on Infectious Diseases, Epidemiology, Virology, Pediatrics, Perinatology and Child Health and Hepatology, having authored 17 papers that have together received 376 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), HIV Research and Treatment (6 papers), Pharmacological Effects and Toxicity Studies (4 papers), Hepatitis C virus research (3 papers), HIV-related health complications and treatments (2 papers), Tuberculosis Research and Epidemiology (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Virology (169 citations), Infectious Diseases (281 citations), Emergency Medicine (73 citations), Pediatrics, Perinatology and Child Health (61 citations) and Hepatology (24 citations). Michael Zilly has collaborated with scholars based in Germany and Austria. Frequent co-authors include Peter Langmann, Hartwig Klinker, Benedikt Weißbrich, Ralf Winzer, Steffen Desch, Franz Tollmann, Jörg Schubert, Ernst Richter, Friedrich Kluge and Andreas Benesic. Their work appears in journals such as Journal of Chromatography B, Infection, Annals of Clinical Microbiology and Antimicrobials, Journal of Clinical Pharmacy and Therapeutics and Current Pharmaceutical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.